Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,054,963
-$135,164 QoQ
Shares Held
85,339
+9.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#949
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. PFE ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
This page
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
|
203 | $243,484 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,054,963 | 85,339 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,190,127 | 77,996 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,843,347 | 74,030 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,782,351 | 69,951 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $310,005 | 12,789 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $337,123 | 13,304 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $344,332 | 12,979 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $388,548 | 13,426 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $362,564 | 12,958 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $368,187 | 13,268 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $400,641 | 13,916 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $478,875 | 14,437 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $572,208 | 15,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $668,589 | 16,387 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,002,613 | 19,567 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $866,404 | 19,799 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,085,091 | 20,696 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,075,935 | 20,783 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,285,695 | 21,773 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $948,585 | 22,055 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $882,000 | 22,523 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $811,552 | 22,400 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $875,967 | 23,797 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $841,456 | 22,928 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $764,297 | 23,373 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $778,658 | 23,856 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||